ATAI LIFE SCIENCES NV (ATAI) Stock News
NASDAQ:ATAI - Nasdaq - NL0015000DX5 - Common Stock - Currency: USD
ATAI Latest News and Analysis
atai Life Sciences Announces Pricing of Public Offering of Common Shares
atai Life Sciences Announces Pricing of Public Offering of Common Shares
NEW YORK and BERLIN, Feb. 12, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical...
Wondering what's happening in today's after-hours session?
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
atai Life Sciences Announces Proposed Public Offering of Common Shares
atai Life Sciences Announces Proposed Public Offering of Common Shares
NEW YORK and BERLIN, Feb. 12, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical...
atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder
- A single dose of BPL-003, combined with relapse prevention therapy, produced meaningful and sustained reductions in alcohol use, with 50% of patients...
atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health
- Srinivas Rao M.D., Ph.D. succeeds as sole Chief Executive Officer- Kevin Craig, M.D. promoted to Chief Medical Officer- Glenn Short, Ph.D. promoted to...
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Q3 2024 earnings ...
atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
NEW YORK and BERLIN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical...
ATAI Stock Earnings: ATAI Life Sciences Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ATAI Life Sciences (NASDAQ:ATAI) just reported results for the second quarter o...
ATAI Stock Earnings: ATAI Life Sciences Misses EPS for Q2 2024
ATAI stock results show that ATAI Life Sciences missed analyst estimates for earnings per share the second quarter of 2024.
atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
atai Reports Q2 2024 Financial Results and Corporate Updates...
atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference in August 2024...
3 Dirt-Cheap Drug Developers With Blockbuster Potential
These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent.
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
These psychedelic drug stocks aren't as radical as once thought as institutional awareness and emphasize on their potential increases.